発表論文2024年度

2024-2025

2024年度の発表論文数は69報です。
2022年度の発表論文(16報)はこちら、2023年度の発表論文(72報)はこちらからご確認ください。

  1. Chambaro HM, Hayashida K, Moonga LC, Shawa M, Muleya W, Chizimu J, Squarre D, Sugi T, Yamagishi J, Ogata S, Kajihara M, Sawa H, Sanjoba C, Mwase ET, Chilengi R, Munsaka GH, Sarenje KL, Mulunda NR, Mutengo MM, Namangala B, Goto Y.
    “A high prevalence of dogs seropositive to Leishmania in Zambia”
    Parasitol Int.,108,103081. Online ahead of print. (2025 Apr 24),
    DOI: 10.1016/j.parint.2025.103081
  2. Shawa M, Hayashida K, Nao N, Paudel A, Kamboyi H, Chambaro H, Mulavu M, Khumalo CS, Nundwe M, Zorigt T, Nakamura C, Qiu Y, Kawai N, Kasanga M, Chizimu J, Moonga L, Ndebe J, Simbotwe M, Ogata S, Samutela M, Nakajima C, Chilengi R, Mutengo M, Kajihara M, Sawa H, Hang’ombe B, Suzuki Y, Higashi H.
    “Development of a PCR-dipstick DNA chromatography-based tool for the detection of CTX-M- and TEM-producing Escherichia coli and Klebsiella pneumoniae isolated from patients in Kafue and Katete districts of Zambia”
    BMC Infect Dis.,25(1),541. (2025 Apr 16),
    DOI: 10.1186/s12879-025-10628-9
  3. Kawakita T, Sekiya T, Kameda Y, Nomura N, Ohno M, Handabile C, Yamaya A, Fukuhara H, Anraku Y, Kita S, Toba S, Tsukamoto H, Sawa T, Oshiumi H, Itoh Y, Maenaka K, Sato A, Sawa H, Suzuki Y, Brown LE, Jackson DC, Kida H, Matsumoto M, Seya T, Shingai M.
    “ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction”
    J Virol.,e0229024. Online ahead of print. (2025 Apr 15),
    DOI: 10.1128/jvi.02290-24
  4. Singano N, Kainga H, Chatanga E, Nkhoma J, Njunga G, Chulu J, Tembo R, Sawa H, Muleya W.
    “One Health Lens on Rabies: Human-Bat Interactions and Genomic Insights of Rabies Virus in Rural Lilongwe, Malawi”
    Trop Med Infect Dis.,10(4),95. (2025 Apr 4),
    DOI: 10.3390/tropicalmed10040095
  5. Suzuki Y, Yakuwa M, Sato M, Samaridou E, Beck-Broichsitter M, Maeki M, Tokeshi M, Yamada Y, Harashima H, Sato Y.
    “Splenic B cell-Targeting Lipid Nanoparticles for Safe and Effective mRNA Vaccine Delivery”
    J Control Release.,382,113687.Epub 2025 Apr 3.(2025 Apr 3),
    DOI: 10.1016/j.jconrel.2025.113687
  6. Uemura K, Sato T, Aoki K, Yamamoto S, Ogasawara N, Saito A, Wada T, Kuronuma K, Nakajima C, Suzuki Y, Horiuchi M, Chiba H, Takahashi S, Yokota S-I.
    “Rapid and Integrated Bacterial Evolution Analysis unveils gene mutations and clinical risk of Klebsiella pneumoniae”
    Nat Commun.,16(1),2917.(2025 Mar 25),
    DOI: 10.1038/s41467-025-58049-1
  7. Kuwata K, Otsu K, Inoha S, Kimura Y, Aoki H, Sakoda Y.
    “Negative impact of porcine circovirus type 2 infection on the efficacy of classical swine fever vaccine in a field farm”
    J Vet Med Sci.,87(5),509-516.(2025 Mar 24),Epub 2025 Mar 24,
    DOI: 10.1292/jvms.24-0496
  8. Anraku Y, Kita S, Onodera T, Sato A, Tadokoro T, Ito S, Adachi Y, Kotaki R, Suzuki T, Sasaki J, Shiwa-Sudo N, Iwata-Yoshikawa N, Nagata N, Kobayashi S, Kazuki Y, Oshimura M, Nomura T, Sasaki M, Orba Y, Suzuki T, Sawa H, Hashiguchi T, Fukuhara H, Takahashi Y, Maenaka K.
    “Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants”
    Commun Biol.,8(1),483.(2025 Mar 22),
    DOI: 10.1038/s42003-025-07827-0
  9. Rice A, Gonzalez G, Carr M, Dean J, O’Byrne E, Aarts L, Vennema H, Banka W, Bennett C, Cleary S, Domegan L, O’Donnell J, O’Leary M, Goya S, Presser L, Meijer A, Martin G, Sawa H, Waters A, De Gascun C, Hare D.
    “Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic”
    Microb Genom.,11(3),001379.(2025 Mar 17),
    DOI: 10.1099/mgen.0.001379
  10. Suzuki Y, Yakuwa M, Sato M, Samaridou E, Beck-Broichsitter M, Maeki M, Tokeshi M, Yamada Y, Harashima H, Sato Y.
    “Marginal-zone B cells as promising targets of an mRNA-loaded, lipid-nanoparticle cancer vaccine”
    Next Nanotechnology.,100154.(2025 Mar 15),
    DOI: 10.1016/j.nxnano.2025.100154
  11. Mutmainah, Murai Y, Fujimoto A, Kawamura R, Kitamura A, Koolath S, Usuki S, Sasaki M, Orba Y, Igarashi Y, Sawa H, Sato A, Monde K.
    “Malabaricone C isolated from edible plants as a potential inhibitor of SARS-CoV-2 infection”
    Sci Rep.,15(1),8518.(2025 Mar 12),
    DOI: 10.1038/s41598-024-83633-8
  12. Izumi F, Makino M, Sasaki M, Nakagawa K, Takahashi T, Nishiyama S, Fujii Y, Okajima M, Masatani T, Igarashi M, Sawa H, Sugiyama M, Ito N.
    “Functional dissection of the C-terminal domain of rabies virus RNA polymerase L protein”
    J Virol.,99(4),e0208224,Epub 2025 Mar 11.(2025 Mar 11),
    DOI: 10.1128/jvi.02082-24
  13. Mahmoud A. Younis, Yusuke Sato, Yaser H.A. Elewa, Hideyoshi H.
    “Harnessing the composition of lipid nanoparticles to selectively deliver mRNA to splenic immune cells for anticancer vaccination”
    Drug Deliv Transl Res.,Online ahead of print.(2025 Mar 7),
    DOI: 10.1007/s13346-025-01824-w
  14. Fujisawa M, Onodera T, Kuroda D, Kewcharoenwong C, Sasaki M, Itakura Y, Yumoto K, Nithichanon A, Ito N, Takeoka S, Suzuki T, Sawa H, Lertmemongkolchai G, Takahashi Y.
    “Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination”
    NPJ Vaccines.,10(1),39.(2025 Feb 23),
    DOI: 10.1038/s41541-025-01073-5
  15. Harada R, Hiono T, Igarashi M, Kobayashi D, Ban H, Isoda N, Sakoda Y.
    “Altered receptor-binding specificity of gull-adapted H13 avian influenza viruses corresponds to their unique host preferences”
    Virology.,605,110460,(2025 Feb 21),Epub 2025 Feb 21
    DOI: 110.1016/j.virol.2025.110460
  16. Usui M, Sabala RF, Morita S, Fukuda A, Tsuyuki Y, Torii K, Nakamura Y, Okamura K, Komatsu T, Sasaki J, Nakajima C, Suzuki Y.
    ” Antimicrobial susceptibility and genetic diversity of Staphylococcus pseudintermedius isolated from companion animals and human clinical patients in Japan: potential zoonotic implications.”
    J Glob Antimicrob Resist.,Online ahead of print.(2025 Feb 18),
    DOI: 10.1016/j.jgar.2025.02.010
  17. Iwakawa K, Sato R, Konaka M, Yamada Y, Harashima H, Sato Y.
    ” Cubic Phase-Inducible Zwitterionic Phospholipids Improve the Functional Delivery of mRNA”
    Adv Sci (Weinh).,e2413016,Epub 2025 Feb 17.(2025 Feb 17),
    DOI: 10.1002/advs.202413016
  18. Kobayashi M, Huynh LT, Ogino S, Hew LY, Koyasu M, Kamata H, Hiono T, Isoda N, Sakoda Y.
    ” Generation of Vaccine Candidate Strains That Antigenically Match Classical Swine Fever Virus Field Strains”
    Vaccines (Basel).,13(2),188.(2025 Feb 14),
    DOI: 10.3390/vaccines13020188
  19. Kobayashi D, Hiono T, Arakawa H, Kaji H, Ohkawara A, Ichikawa T, Ban H, Isoda N, Sakoda Y.
    ” Deglycosylation and truncation in the neuraminidase stalk are functionally equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza virus in chickens”
    J Virol., 99(3),e0147824.Epub 2025 Feb 14.(2025 Feb 14),
    DOI: 10.1128/jvi.01478-24
  20. Kochayoo P, Moriyama S, Kotaki R, Thawornpan P, Malee C, Leepiyasakulchai C, Ntumngia FB, Adams JH, Takahashi Y, Chootong P.
    “Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants”
    PLoS Pathog.,21(1),e1012866.(2025 Jan 23),
    DOI: 10.1371/journal.ppat.1012866
  21. Nakase M, Thapa J, Batbaatar V, Khurtsbaatar O, Enkhtuul B, Unenbat J, Lkham B, Tuyanyok A, Saechan B, Higashi H, Hayashida K, Suzuki Y, Nakajima C, Kimura T.
    “A novel ready-to-use loop-mediated isothermal amplification (LAMP) method for detection of Burkholderia mallei and B. pseudomallei”
    BMC Microbiol.,25(1),36.(2025 Jan 21),
    DOI: 10.1186/s12866-024-03737-z
  22. Harima H, Qiu Y, Sasaki M, Ndebe J, Penjaninge K, Simulundu E, Kajihara M, Ohnuma A, Matsuno K, Nao N, Orba Y, Takada A, Ishihara K, Hall WW, Hang’ombe BM, Sawa H.
    “First identification and whole genome characterization of rotavirus C in pigs in Zambia”
    Virology.,603,110385. (2024 Dec 31),
    DOI: 10.1016/j.virol.2024.110385
  23. Munjita SM, Kalonda A, Mubemba B, Vanaerschot M, Tato C, Mwakibete L, Tembo J, Chitanga S, Changula K, Kajihara M, Muleya W, Sawa H, Takada A, Bates M, Munsaka S, Simulundu E.
    “Evidence of multiple bacterial, viral, and parasitic infectious disease agents in Mastomys natalensis rodents in riverine areas in selected parts of Zambia”
    Infect Ecol Epidemiol.,15(1),2441537. (2024 Dec 31),
    DOI: 10.1080/20008686.2024.2441537
  24. Kobayashi H, Chambaro H, Tabata K, Ariizumi T, Phongphaew W, Ndashe K, Ndebe J, Fandamu P, Kobayashi S, Ito N, Sasaki M, Hang’ombe BM, Simulundu E, Orba Y, Sawa H.
    “African lineage 1a West Nile virus isolated from crocodiles exhibits low neuroinvasiveness in mice”
     J Gen Virol.,105(11),002051.(2024 Nov 26),
    DOI: 10.1099/jgv.0.002051
  25. Fukuda A, Kozaki Y, Kürekci C, Suzuki Y, Nakajima C, Usui M.
    “Spreading Ability of Tet(X)-Harboring Plasmid and Effect of Tetracyclines as a Selective Pressure”
    Microb Drug Resist.,30(12),489-501, Epub 2024 Nov 21.(2024 Nov 21),
    DOI: 10.1089/mdr.2024.0115
  26. Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T.
    “X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates”
    Antiviral Res.,232,106039, Epub 2024 Nov 19.(2024 Nov 19),
    DOI: 10.1016/j.antiviral.2024.106039
  27. Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T.
    “Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case”
    EBioMedicine,110, 105439, Epub 2024 Nov 1.(2024 Nov 1),
    DOI: 10.1016/j.ebiom.2024.105439
  28. Harima H, Qiu Y, Sasaki M, Ndebe J, Penjaninge K, Simulundu E, Kajihara M, Ohnuma A, Matsuno K, Nao N, Orba Y, Takada A, Ishihara K, Hall WW, Hang’ombe BM, Sawa H.
    “A first report of rotavirus B from Zambian pigs leading to the discovery of a novel VP4 genotype P[9]”
    Virol J.,21(1),263,(2024 Oct 24),
    DOI: 10.1186/s12985-024-02533-5
  29. Chizimu JY, Mudenda S, Yamba K, Lukwesa C, Chanda R, Nakazwe R, Shawa M, Chambaro H, Kamboyi H, Kalungia AC, Chanda D, Fwoloshi S, Jere E, Mufune T, Munkombwe D, Lisulo P, Mateele T, Thapa J, Kapolowe K, Sinyange N, Sialubanje C, Kapata N, Mpundu M, Masaninga F, Azam K, Nakajima C, Siyanga M, Bakyaita NN, Wesangula E, Matu M, Suzuki Y, Chilengi R.
    “Antibiotic use and adherence to the WHO AWaRe guidelines across 16 hospitals in Zambia: a point prevalence survey”
    JAC Antimicrob Resist.,6(5),dlae170,(2024 Oct 24),
    DOI: 10.1093/jacamr/dlae170
  30. Hashiba K, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Suzuki Y, Ebe H, Okazaki A, Harashima H, Sato Y.
    “Impact of Lipid Tail Length on the Organ Selectivity of mRNA-Lipid Nanoparticles”
    Nano Lett.,24(41),12758-12767,(2024 Oct 7),
    DOI: 10.1021/acs.nanolett.4c02566
  31. Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Maenaka K, Sato K, Hashiguchi T.
    “Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1”
    Nat Commun.,15(1),8574,(2024 Oct 7),
    DOI: 10.1038/s41467-024-52808-2
  32. Usui M , Fukuda A, Azuma T, Kobae Y, Hori Y, Kushima M, Katada S, Nakajima C, Suzuki Y.
    “Vermicomposting reduces the antimicrobial resistance in livestock waste”
    Journal of Hazardous Materials Advances.,Volume 16,article100491,(2024 Oct 2),
    DOI: 10.1016/j.hazadv.2024.100491
  33. Chizimu JY, Mudenda S, Yamba K, Lukwesa C, Chanda R, Nakazwe R, Simunyola B, Shawa M, Kalungia AC, Chanda D, Chola U, Mateele T, Thapa J, Kapolowe K, Mazaba ML, Mpundu M, Masaninga F, Azam K, Nakajima C, Suzuki Y, Bakyaita NN, Wesangula E, Matu M, Chilengi R.
    “Antimicrobial Stewardship Situation Analysis in Selected Hospitals in Zambia: Findings and Implications from a National Survey”
    Front Public Health.,12,1367703,eCollection 2024,(2024 Sep 27),
    DOI: 10.3389/fpubh.2024.1367703
  34. Intaruck K, Tabata K, Itakura Y, Kawaguchi N, Kishimoto M, Setiyono A, Handharyani E, Harima H, Kimura T, Hall WW, Orba Y, Sawa H, Sasaki M.
    “Characterization of a mammalian orthoreovirus isolated from the large flying fox, Pteropus vampyrus, in Indonesia”
    J Gen Virol.,105(9),(2024 Sep 25),
    DOI: 10.1099/jgv.0.002028
  35. Ichikawa T, Hiono T, Okamatsu M, Maruyama J, Kobayashi D, Matsuno K, Kida H, Sakoda Y.
    “Hemagglutinin and neuraminidase of a non-pathogenic H7N7 avian influenza virus coevolved during the acquisition of intranasal pathogenicity in chickens”
    Arch Virol.,169(10),207,(2024 Sep 22),
    DOI: 10.1007/s00705-024-06118-z
  36. Yajima H, Nomai T, Okumura K, Maenaka K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Hashiguchi T, Sato K.
    ” Molecular and structural insights into SARS-CoV-2 evolution: from BA. 2 to XBB subvariants”
    mBio., 15(10),e0322023,Epub 2024 Sep 16(2024 Sep 16),
    DOI: 10.1128/mbio.03220-23
  37. Kotaki R, Moriyama S, Oishi S, Onodera T, Adachi Y, Sasaki E, Ishino K, Morikawa M, Takei H, Takahashi H, Takano T, Nishiyama A, Yumoto K, Terahara K, Isogawa M, Matsumura T, Shinkai M, Takahashi Y.
    “Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution towards the latest variants”
    Sci Transl Med.,16(761),eadp9927,Epub 2024 Aug 21.(2024 Aug 21),
    DOI: 10.1126/scitranslmed.adp9927
  38. Koide K, Kim H, Whelan MVX, Belotindos LP, Tanomsridachchai W, Changkwanyeun R, Usui M, Ó’Cróinín T, Nakajima C, Suzuki Y.
    “WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni
    Microbiol Spectr.,e0432223,(2024 Aug 20),Online ahead of print.
    DOI: 10.1128/spectrum.04322-23
  39. Tabata K, Kobayashi S, Itakura Y, Gonzalez G, Kabamba CF, Saito S, Sasaki M, Hall WW, Sawa H, Orba Y.
    “Increased production of orthoflavivirus single-round infectious particles produced in mammalian cells at a suboptimal culture temperature of 28°C”
    J Virol Methods.,329,115007,(2024 Aug 16),Online ahead of print.
    DOI: 10.1016/j.jviromet.2024.115007
  40. Kawaguchi N, Itakura Y, Intaruck K, Ariizumi T, Harada M, Inoue S, Maeda K, Ito N, Hall WW, Sawa H, Orba Y, Sasaki M.
    “Reverse genetic approaches allowing the characterization of the rabies virus street strain belonging to the SEA4 subclade.”
    Sci Rep.,14(1),18509,(2024 Aug 9),
    DOI: 10.1038/s41598-024-69613-y
  41. Hew YL, Hiono T, Monne I, Nabeshima K, Sakuma S, Kumagai A, Okamura S, Soda K, Ito H, Esaki M, Okuya K, Ozawa M, Yabuta T, Takakuwa H, Nguyen LB, Isoda N, Miyazawa K, Onuma M, Sakoda Y.
    “Cocirculation of Genetically Distinct Highly Pathogenic Avian Influenza H5N5 and H5N1 Viruses in Crows, Hokkaido, Japan”
    Emerg Infect Dis.,30(9),1912-1917,Epub 2024 Aug 6.(2024 Aug 6),
    DOI: 10.3201/eid3009.240356
  42. Konishi K, Kusakabe S, Kawaguchi N, Shishido T, Ito N, Harada M, Inoue S,Maeda K, Hall WW, Orba Y, Sawa H, Sasaki M, Sato A.
    “β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus”
    Antiviral Res.,229,105977, Epub 2024 Jul 31 (2024 Sep),
    DOI: 10.1016/j.antiviral.2024.105977
  43. Usui M, Azumab T, Katada S, Fukuda A , SuzukibY, NakajimaC , Tamura Y.
    ” Hyperthermophilic composting of livestock waste drastically reduces antimicrobial resistance”
    Waste Management Bulletin.,2(3),241-248 (2024 Aug 03),
    DOI: 10.1016/j.wmb.2024.8.1
  44. Pandit A, Thapa J, Sadaula A, Suzuki Y, Nakajima C, Mikota SK, Subedi N, Shrestha BK, Shimozuru M, Shrestha B, Raya B, Chaudhary S, Paudel S, Tsubota T
    “Epidemiology and molecular characterization of Mycobacterium tuberculosis including a drug-resistant strain associated with mortality of Asian elephants in Nepal 2019-2022”
    Tuberculosis (Edinb).,148,102550.(2024 Jul 26),Online ahead of print.
    DOI: 10.1016/j.tube.2024.102550
  45. Fukuhara H, Yumoto K, Sako M, Kajikawa M, Ose T, Kawamura M, Yoda M, Chen S, Ito Y, Takeda S, Mwaba MH, Wang J, Hashiguchi T, Kamishikiryo J, Maita N, Kitatsuji C, Takeda M, Kuroki K, Maenaka K
    “Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination”
    Elife.,12,RP88929.(2024 Jul 24),
    DOI: 10.7554/eLife.88929
  46. Misapa MC, Bwalya EC, Moonga L, Zimba J, Kabwali ES, Silombe M, Mulwanda EC,Mulenga C, Simuunza MC, Sawa H, Hang’ombe B, Muleya W
    “Rabies Realities:Navigating Barriers to Rabies Control in Rural Zambia-A Case Study of Manyinga and Mwansabombwe Districts”
    Trop Med Infect Dis.,9(7),161.(2024 Jul 18),
    DOI: 10.3390/tropicalmed9070161
  47. Ketkhao P, Utrarachkij F, Parikumsil N, Poonchareon K, Kerdsin A, Ekchariyawat P, Nakajima C, Suzuki Y, Suthienkul O.
    “Phylogenetic diversity and virulence gene characteristics of Escherichia coli from pork and patients with urinary tract infections in Thailand”
    PLoS One.19(7),e0307544,eCollection 2024.(2024 Jul 25).
    DOI: 10.1371/journal.pone.0307544
  48. Urtasun-Elizari JM, Ma R, Pickford H, Farrell D, Gonzalez G, Perets V, Nakajima C, Suzuki Y, MacHugh DE, Bhatt A, Gordon SV.
    “Functional analysis of the Mycobacterium bovis AF2122/97 PhoPR system”
    Tuberculosis (Edinb).,148,102544.(2024 Jul 14),Online ahead of print.
    DOI: 10.1016/j.tube.2024.102544
  49. Kishimoto M, Itakura Y, Tabata K, Komagome R, Yamaguchi H, Ogasawara K, Nakao R, Qiu Y, Sato K, Kawabata H, Kajihara M, Monma N, Seto J, Shigeno A, Horie M, Sasaki M, Hall WW, Sawa H, Orba Y, Matsuno K.
    “A wide distribution of Beiji nairoviruses and related viruses in Ixodes ticks in Japan”
    Ticks Tick Borne Dis.,15(6),102380,(2024 Jul 11),
    DOI: 10.1016/j.ttbdis.2024.102380
  50. Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K, Genotype to Phenotype Japan (G2P Japan).
    “Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant”
    Microbiol Immunol.,68(9),305-330,Epub 2024 Jul 4(2024 Jul 4),
    DOI: 10.1111/1348-0421.13165
  51. Ito H, Tamura T, Wang L, Mori K, Tsuda M, Suzuki R, Suzuki S, Yoshimatsu K, Tanaka S, Fukuhara T.
    “Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis”
    Microbiol Immunol.,68(7),237-247,Epub 2024 Jun 4(2024 Jun 4),
    DOI: 10.1111/1348-0421.13157
  52. Takeichi K, Fukuda A, Shono C, Ota N, Nakajima C, Suzuki Y, Usui M.
    “Association of toxin-producing Clostridioides difficile with piglet diarrhea and potential transmission to humans”
    J Vet Med Sci.,86(7),769-776,Epub 2024 May 27.(2024 Jul 2),
    DOI: 10.1292/jvms.24-0051
  53. Toyting J, Supha N, Thongpanich Y, Thapa J, Nakajima C, Suzuki Y, Utrarachkij F.
    “Wide distribution of plasmid mediated quinolone resistance gene, qnrS, among Salmonella spp. isolated from canal water in Thailand”
    J Appl Microbiol.,29(16),2300505,(2024 June 22),
    DOI: 110.1093/jambio/lxae134
  54. Suwanthada P, Kongsoi S, Jayaweera S, Akapelwa ML, Thapa J, Nakajima C, Suzuki Y.
    “Interplay between Amino Acid Substitution in GyrA and QnrB19: Elevating Fluoroquinolone Resistance in Salmonella Typhimurium”
    ACS Infect Dis.,10(8),2785-2794,Epub 2024 Jun 19(2024 Jun 19),
    DOI: 10.1021/acsinfecdis.4c00150
  55. Thuansuwan W, Chuchottaworn C, Nakajima C, Suzuki Y, Chaichanawongsaroj N.
    “Biphasic Medium Using Nicotinamide for Detection of PyrazinamideResistance in Mycobacterium tuberculosis”
    Antibiotics (Basel).,13(6),563,(2024 June 16),
    DOI: 10.3390/antibiotics13060563
  56. Yamamoto H, Tamura T, Ichikawa T, Taguchi Y, Mori K, Oguri S, Suzuki R, Suzuki S, Teshima T, Fukuhara T.
    “Generation of recombinant viruses directly from clinical specimens of COVID-19 patients”
    J Clin Microbiol.,62(7),e0004224,Epub 2024 Jun 14,(2024 June 14),
    DOI: 10.1128/jcm.00042-24
  57. Saasa N, M’kandawire E, Ndebe J, Mwenda M, Chimpukutu F, Mukubesa AN, Njobvu F, Shempela DM, Sikalima J, Chiyesu C, Muvwanga B, Nampokolwe SM, Sulwe C, Khondiwa T, Jennings T, Kamanga A, Simulundu E, Mulube C, Mwasinga W, Mumeka J, Simwanza J, Sakubita P, Kapona O, Mulenga CSA, Chipoya M, Musonda K, Kapata N, Sinyange N, Kapina M, Siwila J, Shawa M, Kajihara M, Takada A, Sawa H, Choonga SA, Chilengi R, Muyunda E, Nalubamba KS, Hang’ombe BM.
    “Detection of Human Adenovirus and Rotavirus in Wastewater in Lusaka, Zambia: Demonstrating the Utility of Environmental Surveillance for the Community”
    Pathogens.,13(6),486,(2024 June 7),
    DOI: 10.3390/pathogens13060486
  58. Fujita S, Plianchaisuk A, Deguchi S, Ito H, Nao N, Wang L, Nasser H, Tamura T, Kimura I, Kashima Y, Suzuki R, Suzuki S, Kida I, Tsuda M, Oda Y, Hashimoto R, Watanabe Y, Uriu K, Yamasoba D, Guo Z, Hinay AA Jr, Kosugi Y, Chen L, Pan L, Kaku Y, Chu H, Donati F, Temmam S, Eloit M, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Suzuki Y; Genotype to Phenotype Japan(G2P-Japan) Consortium; Ito J, Ikeda T, Tanaka S, Matsuno K, Fukuhara T, Takayama K, Sato K.
    “Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236”
    EBioMedicine.,104,105181,Epub 2024 Jun 4(2024 June 4),
    DOI: 10.1016/j.ebiom.2024.105181
  59. Sinyawa T, Shawa M, Muuka GM 3, Goma F, Fandamu P, Chizimu JY, Khumalo CS, Mulavu M, Ngoma M, Chambaro HM, Kamboyi HK, Kajihara M, Sawa H, Suzuki Y, Higashi H, Mainda G, Munyeme M, Muma JB, Nyantakyi CO, Egyir B Sinyawa T, Shawa M, Muuka GM 3, Goma F, Fandamu P, Chizimu JY, Khumalo CS, Mulavu M, Ngoma M, Chambaro HM, Kamboyi HK, Kajihara M, Sawa H, Suzuki Y, Higashi H, Mainda G, Munyeme M, Muma JB, Nyantakyi CO, Egyir B, Hang’ombe BM. “Antimicrobial Use Survey and Detection of ESBL-Escherichia coli in Commercial and Medium-/Small-Scale Poultry Farms in Selected Districts of Zambia” Antibiotics.,13(5),467,(2024 May 20),
    DOI: 10.3390/antibiotics13050467
  60. Furukawa R, Kuwatani M, Jiang JJ, Tanaka Y, Hasebe R, Murakami K, Tanaka K, Hirata N, Ohki I, Takahashi I, Yamasaki T, Shinohara Y, Nozawa S, Hojyo S, Kubota SI, Hashimoto S, Hirano S, Sakamoto N, Murakami M.
    “GGT1 is a SNP eQTL gene involved in STAT3 activation and associated with the development of Post-ERCP pancreatitis”
    Sci Rep.,14(1),12224,(2024 May 28),
    DOI: 10.1038/s41598-024-60312-2
  61. Tamura T, Ito H, Torii S, Wang L, Suzuki R, Tsujino S, Kamiyama A, Oda Y, Tsuda M, Morioka Y, Suzuki S, Shirakawa K, Sato K, Yoshimatsu K, Matsuura Y, Iwano S, Tanaka S, Fukuhara T.
    “Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection”
    iScience.,27(5),109647,eCollection 2024 May 17(2024 May 17),
    DOI: 10.1016/j.isci.2024.109647
  62. Kobayashi S, Kawai S, Fukuda Y, Eguchi H, Maezono K, Thammahakin P, Sawa H, Kariwa H.
    “Rab27a promotes degradation of West Nile virus E protein in the lysosome”
    iScience.,27(4),109539,eCollection 2024 Apr 19(2024 April 19),
    DOI: 10.1016/j.isci.2024.109539
  63. Gonzalez G, Carr M, Kelleher TM, O’Byrne E, Banka W, Keogan B, Bennett C, Franzoni G, Keane P, Kenna C, Meredith LW, Fletcher N, Urtasun-Elizari JM, Dean J, Browne C, Lyons F, Crowley B, Igoe D, Robinson E, Martin G, Connell J, De Gascun CF, Hare D.
    “Multiple introductions of monkeypox virus to Ireland during the international mpox outbreak, May 2022 to October 2023”
    Euro Surveill.,29(16),2300505,(2024 April 18),
    DOI: 10.2807/1560-7917.ES.2024.29.16.2300505
  64. Takada K, Orba Y, Kida Y, Wu J, Ono C, Matsuura Y, Nakagawa S, Sawa H, Watanabe T.
    “Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution”
    J Virol., 21(1).,e1012866,Epub 2024 Apr 16.(2024 April 16)
    DOI: 10.1128/jvi.01784-23
  65. Shawa M, Paudel A, Chambaro H, Kamboyi H, Nakazwe R, Alutuli L, Zorigt T, Sinyawa T, Samutela M, Chizimu J, Simbotwe M, Hayashida K, Nao N, Kajihara M, Furuta Y, Suzuki Y, Sawa H, Hang’ombe B, Higashi H.
    “Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015-2020 in a national referral hospital of Zambia.”
    PLoS One.,19(4),e0302053,(2024 April 16),
    DOI: 10.1371/journal.pone.0302053
  66. Sabala RF, Fukuda A, Nakajima C, Suzuki Y, Usui M, Elhadidy M.
    “Carbapenem and colistin-resistant hypervirulent Klebsiella pneumoniae: An emerging threat transcending the egyptian food chain.”
    J Infect Public Health.,17(6),1037-1046,Epub 2024 Apr 16.(2024 April 16),
    DOI: 10.1016/j.jiph.2024.04.010
  67. Yamba K, Chizimu JY, Mudenda S, Lukwesa C, Raphael Chanda R, Nakazwe R, Simunyola B, Shawa M, Kalungia A, Ojoku D, Mateele T, Thapa J, Kapolowe K, Mazaba ML, Mpundu M, Masaninga F, Azam K, Nakajima C, Suzuki Y, Bakyaita NN, Wesangula E, Matu M, Chilengi R
    “Assessment of Antimicrobial Resistance Laboratory-based Surveillance Capacity of Hospitals in Zambia: Findings and Implications for System Strengthening. ”
    J Hosp Infect.,S0195-6701(24),00114-2,(2024 April 15), Online ahead of print.
    DOI: 10.1016/j.jhin.2024.03.014
  68. Miura-Ajima N, Suwanthada P, Kongsoi S, Kim H, Pachanon R, Koide K, Mori S, Thapa J, Nakajima C, Suzuki Y.
    “Effect of WQ-3334 on Campylobacter jejuni carrying a DNA gyrase with dominant amino acid substitutions conferring quinolone resistance. ”
    J Infect Chemother.,30(10),1028-1034,Epub 2024 Apr 4(2024 April 4).
    DOI: 10.1016/j.jiac.2024.04.002
  69. Toyting J, Nuanmuang N, Utrarachkij F, Supha N, Thongpanich Y, Leekitcharoenphon P, Aarestrup FM, Sato T, Thapa J, Nakajima C, Suzuki Y.
    “Genomic Analysis of Salmonella Isolated from Canal Water in Bangkok, Thailand.”
    Microbiol Spectr.,e0421623,(2024 April 2), Online ahead of print.
    DOI: 10.1128/spectrum.04216-23